ALIVE VC

ALIVE VC is a pioneering mid-to-late stage HealthTech venture capital firm based in Israel. The firm specializes in accelerating the growth of innovative healthcare technologies by leveraging an exclusive ecosystem of strategic partners, including leading hospital chains, health maintenance organizations (HMOs), and financial institutions. This collaborative approach supports portfolio companies in their clinical and commercial expansion, aiming to improve the quality of life for millions of people.

The firm's investment strategy focuses on companies with the highest potential to become the gold standard in a broad range of disciplines, including medical devices, diagnostics, digital health, healthcare IT, and AI and ML. ALIVE VC seeks highly fundable companies with strong management, broad intellectual property protection, and a proven track record of execution. The firm emphasizes in-depth understanding of clinical workflows, product-market fit validation under challenging health economics, and evolving market trends.

ALIVE VC's portfolio includes companies such as Medisafe, Innovalve, Magenta, Cynerio, Beyeonics Vision, Nevia Bio, OncoHost, Navina, Wisdo, Append Medical, and Vessi Medical. The firm has a history of successful exits, including the acquisition of Innovalve by Edwards Lifesciences and Cynerio by Axonius. ALIVE VC's strategic partnerships and active engagement help portfolio companies realize their full potential and achieve large-scale success in the HealthTech sector.